Antenatal glucocorticoid treatment does not reduce chronic lung disease among surviving preterm infants.


BACKGROUND Antenatal glucocorticoid treatment (AGT) is associated with a number of postnatal benefits to the preterm infant, including reduced risk of respiratory distress syndrome, patent ductus arteriosus, intraventricular hemorrhage, and necrotizing enterocolitis. OBJECTIVE To evaluate the hypothesis that maternal AGT not only reduces the risk of… (More)


  • Presentations referencing similar topics